Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-08-24 4:00 pm Sale | 2022-08-22 | 13D | La Jolla Pharmaceutical Company LJPC | TANG CAPITAL PARTNERS LP | 0 0.000% | -9,959,934 (Position Closed) | Filing History |
| 2022-07-25 4:00 pm Purchase | 2022-07-15 | 13G | CytomX Therapeutics, Inc. CTMX | TANG CAPITAL PARTNERS LP | 3,470,900 5.300% | 3,470,900 (New Position) | Filing History |
| 2022-07-11 6:15 pm Unchanged | 2022-07-10 | 13D | La Jolla Pharmaceutical Company LJPC | TANG CAPITAL PARTNERS LP | 9,959,934 39.800% | 0 (Unchanged) | Filing History |
| 2022-06-06 4:00 pm Purchase | 2022-05-26 | 13G | Veru Inc. VERU | TANG CAPITAL PARTNERS LP | 4,130,339 5.200% | 4,130,339 (New Position) | Filing History |
| 2022-06-03 4:00 pm Purchase | 2022-05-24 | 13G | bluebird bio, Inc. BLUE | TANG CAPITAL PARTNERS LP | 186,053 5.200% | 186,053 (New Position) | Filing History |
| 2022-05-26 4:00 pm Purchase | 2022-05-16 | 13G | KalVista Pharmaceuticals, Inc. KALV | TANG CAPITAL PARTNERS LP | 1,400,000 5.700% | 1,400,000 (New Position) | Filing History |
| 2022-05-13 4:00 pm Purchase | 2022-05-03 | 13G | Tarsus Pharmaceuticals, Inc. TARS | TANG CAPITAL PARTNERS LP | 2,091,753 7.900% | 2,091,753 (New Position) | Filing History |
| 2022-04-28 4:00 pm Purchase | 2022-04-18 | 13G | BioAtla, Inc. BCAB | TANG CAPITAL PARTNERS LP | 2,288,900 6.400% | 2,288,900 (New Position) | Filing History |
| 2022-03-24 4:04 pm Purchase | 2022-03-14 | 13G | Altimmune, Inc. ALT | TANG CAPITAL PARTNERS LP | 2,200,000 5.100% | 2,200,000 (New Position) | Filing History |
| 2022-03-04 4:00 pm Purchase | 2022-02-22 | 13G | TCR2 Therapeutics Inc. TCRR | TANG CAPITAL PARTNERS LP | 2,800,000 7.300% | 2,800,000 (New Position) | Filing History |
| 2022-02-14 4:00 pm Sale | 2021-12-31 | 13G | Rocket Pharmaceuticals, Inc. RCKT | TANG CAPITAL PARTNERS LP | 2,531,800 3.900% | -433,685 (-14.62%) | Filing History |
| 2022-02-14 4:00 pm Purchase | 2021-12-31 | 13G | Vincerx Pharma, Inc. VINC | TANG CAPITAL PARTNERS LP | 51,532 4.900% | 51,532 (New Position) | Filing History |
| 2022-02-14 4:00 pm Purchase | 2021-12-31 | 13G | Corvus Pharmaceuticals, Inc. CRVS | TANG CAPITAL PARTNERS LP | 3,101,709 6.700% | 3,101,709 (New Position) | Filing History |
| 2022-02-14 4:00 pm Purchase | 2021-12-31 | 13G | Heron Therapeutics, Inc. HRTX | TANG CAPITAL PARTNERS LP | 7,783,688 7.600% | 144,588 (+1.89%) | Filing History |
| 2022-02-14 4:00 pm Purchase | 2021-12-31 | 13G | aTyr Pharma, Inc. ATYR | TANG CAPITAL PARTNERS LP | 1,113,453 4.000% | 50,000 (+4.70%) | Filing History |
| 2021-12-02 08:30 am Sale | 2021-12-01 | 13D | La Jolla Pharmaceutical Company LJPC | TANG CAPITAL PARTNERS LP | 9,959,934 36.000% | -166,270 (-1.64%) | Filing History |
| 2021-11-26 1:00 pm Sale | 2021-11-23 | 13D | Aptevo Therapeutics Inc. APVO | TANG CAPITAL PARTNERS LP | 0 0.000% | -566 (Position Closed) | Filing History |
| 2021-11-22 5:28 pm Sale | 2021-11-18 | 13D | Aptevo Therapeutics Inc. APVO | TANG CAPITAL PARTNERS LP | 566 18.800% | -515 (-47.65%) | Filing History |
| 2021-11-19 5:08 pm Sale | 2021-11-17 | 13D | Odonate Therapeutics, Inc. ODTC | TANG CAPITAL PARTNERS LP | 0 33.700% | -0 (-19.17%) | Filing History |
| 2021-09-22 08:31 am Purchase | 2021-09-21 | 13G | Corvus Pharmaceuticals, Inc. CRVS | TANG CAPITAL PARTNERS LP | 3,736,184 8.800% | 3,736,184 (New Position) | Filing History |